Numerate
is a biopharmaceutical company that researches and develops drugs for cardiovascular, metabolic and neurodegenerative diseases... Read moreNumerate
is a biopharmaceutical company that researches and develops drugs for cardiovascular, metabolic and neurodegenerative diseases... Read more
2007
PrivateIndependent Company
News
Aug 08, 2019
FinSMEs
Numerate: Numerate Receives $2M SBIR Phase II Award
Jan 07, 2019
Business Wire
Press Release: Numerate : Numerate and Lundbeck Partner to Apply AI Drug Discovery to Unlock Challenges of Neuroscience Research
Sep 12, 2018
FinanzNachrichten
Numerate: Alliance for Artificial Intelligence in Healthcare (AAIH) Convenes in Boston and Basel to Announce Mission and Launch Activities
Jul 30, 2018
BioPortfolio
Numerate: Numerate Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Mar 24, 2018
BioPortfolio
Numerate: Numerate Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Feb 20, 2018
PharmiWeb
Numerate: US Defense Threat Reduction Agency Renews Contract to Support Continued Development of Numerate's Predictive Toxicity System
Dec 31, 2017
BioPortfolio
Numerate: Numerate Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15112017 Prices from USD $250
Nov 15, 2017
Becker's Spine Review
Numerate: NIH awards grant for boosting bone integration of orthopedic devices - 6 notes
Aug 29, 2017
BioPortfolio
Numerate: Numerate Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
Jun 15, 2017
BioPortfolio
Numerate: Takeda & Numerate Apply Artificial Intelligence to Drug Discovery
